Yuki Yokota Selected Research

Yuki Yokota Research Topics

Disease

10	Neoplasms (Cancer) 04/2022 - 01/2014
5	Neoplasm Metastasis (Metastasis) 04/2022 - 04/2018
3	Hepatocellular Carcinoma (Hepatoma) 04/2022 - 03/2015
2	Encephalitis (Encephalitis, Rasmussen) 01/2022 - 06/2020
2	COVID-19 12/2021 - 01/2021
2	Leukocytosis (Pleocytosis) 01/2021 - 12/2020
2	Cholangiocarcinoma 01/2021 - 12/2018
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2014 - 01/2013
1	Brain Diseases (Brain Disorder) 10/2022
1	Triple Negative Breast Neoplasms 04/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Brain Neoplasms (Brain Tumor) 01/2022
1	Cognitive Dysfunction 01/2022
1	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 01/2022
1	Pneumonia (Pneumonitis) 01/2021
1	Infectious Encephalitis 01/2021
1	Rupture 12/2020
1	Abscess 12/2020
1	Bacterial Meningitis 12/2020
1	Low Back Pain (Lumbago) 10/2020
1	Hemorrhage 09/2020
1	MELAS Syndrome (Syndrome, MELAS) 06/2020
1	Pneumoperitoneum 04/2020
1	Gallbladder Diseases (Gall Bladder Disease) 09/2019
1	Xanthogranulomatous cholecystitis 09/2019
1	Lymphoma (Lymphomas) 06/2019
1	Acute Cholecystitis 04/2019
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2018
1	Thrombosis (Thrombus) 12/2018
1	Carcinoma (Carcinomatosis) 04/2018
1	Duodenal Neoplasms (Duodenal Cancer) 04/2018
1	Wounds and Injuries (Trauma) 01/2016
1	Major Depressive Disorder (Major Depressive Disorders) 01/2015
1	Mental Disorders (Mental Disorder) 01/2015
1	Idiopathic Pulmonary Fibrosis 12/2014
1	Genomic Instability 01/2014
1	Body Weight (Weight, Body) 01/2013

Drug/Important Bio-Agent (IBA)

3	AntigensIBA 04/2022 - 03/2015
3	Proteins (Proteins, Gene)FDA Link 04/2022 - 03/2015
3	LigandsIBA 04/2022 - 01/2016
2	ChemokinesIBA 04/2022 - 02/2020
2	VaccinesIBA 04/2022 - 12/2021
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 03/2021 - 01/2015
2	Bleomycin (Blenoxane)FDA LinkGeneric 12/2014 - 01/2013
1	SteroidsIBA 10/2022
1	Immune Checkpoint InhibitorsIBA 04/2022
1	Aspartic Acid (Aspartate)FDA Link 04/2022
1	Mixed Function Oxygenases (Monooxygenases)IBA 04/2022
1	Chemokine ReceptorsIBA 04/2022
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022
1	Acyclovir (Aciclovir)FDA LinkGeneric 01/2022
1	GadoliniumIBA 01/2022
1	AntibodiesIBA 01/2022
1	2019-nCoV Vaccine mRNA-1273IBA 12/2021
1	MicroRNAs (MicroRNA)IBA 03/2021
1	cadherin 5IBA 03/2021
1	PFK15IBA 01/2021
1	tocilizumab (atlizumab)FDA Link 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Interleukin-33IBA 01/2021
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021
1	Methylprednisolone FDA LinkGeneric 01/2021
1	AlarminsIBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2020
1	Glucose (Dextrose)FDA LinkGeneric 12/2020
1	Lactic Acid (Lactate)FDA LinkGeneric 06/2020
1	Mitochondrial DNA (mtDNA)IBA 06/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2020
1	Alanine (L-Alanine)FDA Link 01/2019
1	Cisplatin (Platino)FDA LinkGeneric 12/2018
1	Gemcitabine FDA Link 12/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 04/2018
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2018
1	Monoclonal AntibodiesIBA 03/2015
1	Immunoglobulin Fab FragmentsIBA 03/2015
1	Amino Acids FDA Link 01/2015
1	Ethanolamine (Colamine)IBA 01/2015
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 12/2014
1	Messenger RNA (mRNA)IBA 12/2014
1	Imatinib Mesylate (Gleevec)FDA Link 12/2014
1	Platelet-Derived Growth FactorIBA 12/2014
1	DNA HelicasesIBA 01/2014
1	plerixafor FDA Link 01/2013
1	indium-bleomycinIBA 01/2013

Therapy/Procedure

5	Therapeutics 04/2022 - 01/2013
3	Immunotherapy 10/2022 - 01/2022
2	Hepatectomy 01/2021 - 04/2020
2	Laparoscopic Cholecystectomy 09/2019 - 04/2019
2	Drug Therapy (Chemotherapy) 12/2018 - 04/2018
1	Exercise Therapy (Therapy, Exercise) 10/2020
1	Length of Stay 09/2020
1	Gastrectomy 09/2020
1	Fontan Procedure (Fontan Operation) 04/2020
1	Canes (Cane) 06/2019
1	Lymph Node Excision (Lymph Node Dissection) 12/2018
1	Pancreatectomy 12/2018
1	Radiotherapy 12/2018
1	Splenectomy 12/2018
1	Chemoradiotherapy 12/2018